We are live on ! Find out more

16 hedge funds and large institutions have $2.16M invested in iBio in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

14% more funds holding

Funds holding: 1416 (+2)

11% more capital invested

Capital invested by funds: $1.95M → $2.16M (+$214K)

0% more ownership

Funds ownership: 0%0% (+0%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

IBIO Hedge Fund Activity: Q4 2015 in Review

16 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2015, worth a combined $2.16M — up 11% from $1.95M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IBIO positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $44.6K. The largest seller was BlackRock Institutional Trust, cutting an estimated $25.5K.

  • 16 institutional investors held iBio (IBIO) as of Q4 2015, up from 14 in Q3 2015.
  • Funds reported $2.16M of iBio stock for Q4 2015, up 11% quarter-over-quarter.
  • 3 funds opened new iBio positions in Q4 2015 and 1 closed out, a net change of +2 holders.
  • The largest iBio buyer in Q4 2015 was Citadel Advisors, an estimated $44.6K added.
  • The largest iBio seller in Q4 2015 was BlackRock Institutional Trust, an estimated $25.5K sold.

Based on aggregated 13F filings for Q4 2015.